Background: Maple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disease caused by deficient activity of the branched-chain α-keto acid dehydrogenase (BCKD) enzymatic complex. BCKD is a mitochondrial complex encoded by BCKDHA, BCKDHB, DBT, and DLD genes. MSUD is predominantly caused by Variants in BCKDHA, BCKDHB, and DBT genes encoding the E1α, E1β, and E2 subunits of BCKD complex, respectively. The aim of this study was to characterize the genetic basis of MSUD by identifying the point variants in BCKDHA, BCKDHB, and DBT genes in a cohort of Brazilian MSUD patients and to describe their phenotypic heterogeneity. It is a descriptive cross-sectional study with 21 MSUD patients involving molecular genotyping by Sanger sequencing. Results: Eight new variants predicted as pathogenic were found between 30 variants (damaging and non-damaging) identified in the 21 patients analyzed: one in the BCKDHA gene (p.Tyr120Ter); five in the BCKDHB gene (p.Gly131Val, p.Glu146Glnfs * 13, p.Phe149Cysfs * 9, p.Cys207Phe, and p.Lys211Asn); and two in the DBT gene (p.Glu148Ter and p.Glu417Val). Seventeen pathogenic variants were previously described and five variants showed no pathogenicity according to in silico analysis. Conclusion: Given that most of the patients received late diagnoses, the study results do not allow us to state that the molecular features of MSUD variant phenotypes are predictive of clinical severity.
The Brazilian National Network of Cardiovascular Genomics (RENOMICA) is a research project whose objective is to establish a proof of concept that genetic diagnosis for hereditary cardiovascular diseases is important, feasible, and cost-effective within the Brazilian Unified Health System (SUS). Funded by the Brazilian National Genomics and Precision Health Program (Genomas Brasil) of the Ministry of Health, the study is coordinated by the Brazilian National Institute of Cardiology (INC), with 21 co-participating centers throughout the country. Recruitment, which began in [...] The Brazilian National Network of Cardiovascular Genomics (RENOMICA) is a research project whose objective is to establish a proof of concept that genetic diagnosis for hereditary cardiovascular diseases is important, feasible, and cost-effective within the Brazilian Unified Health System (SUS). Funded by the Brazilian National Genomics and Precision Health Program (Genomas Brasil) of the Ministry of Health, the study is coordinated by the Brazilian National Institute of Cardiology (INC), with 21 co-participating centers throughout the country. Recruitment, which began in
The association of Down syndrome (DS) with Dandy Walker malformation (DWM) is extremely rare, with only 3 cases reported to date. All cases reported have shown a bad life expectancy and a bad developmental outcome. The present case reveals the possibility of a good prognosis. A 19-month-old male patient had successful endoscopic hydrocephalus treatment and a good developmental outcome. He probably had a better outcome because of good DS and DWM prognostic parameters. Our patient suffered from a DWM with vermis identification of 2 fissures and 3 lobes and a DS with a well-preserved tonus, which was not associated with other congenital systemic defects. We may conclude that the prognosis of DS-DWM association may separately depend on the degree of clinical and neurological involvement of each malformation.
Background: Whole-Genome Sequencing (WGS) and Whole-Transcriptome Sequencing (WTS) have emerged as transformative tools in the diagnosis of rare diseases with complex phenotypes. These technologies enable deep analysis of the genome and RNA expression, uncovering structural, intronic, non-coding, and mitochondrial variants that traditional methods might miss, thus facilitating the understanding of gene function and regulation. Methods: We enrolled 8966 patients with suspected rare diseases or hereditary cancer risk syndromes from 21 centers throughout Brazil. Their genomes were sequenced with short, paired-end reads, and diagnostic reports were provided for 7614 of these patients. Results: The overall diagnostic yield was 35.8%, with an additional 5.6% of all Positive reports including gains from WGS compared to other diagnostic tests. In patients with pathogenic/likely pathogenic copy number or structural variants, WGS provided a 10.2% increase in diagnostic yield. Almost 1900 variant/phenotype interpretations were submitted to ClinVar. Conclusion: WGS and WTS are proving to be invaluable resources for shortening the diagnostic odyssey of patients with rare diseases, providing crucial genomic diagnostics, and enriching genetic databases with variant interpretations from underrepresented populations. These technologies have the potential to significantly enhance the precision of healthcare in genetically diverse populations. Key Points for NEJM Editors and Reviewers: Scope : Largest Brazilian rare disease–focused sequencing project to date. Findings : A 35.8% diagnostic yield with notable additional detection of structural, deep intronic, non-coding, and mitochondrial variants. Impact : Shortens diagnostic odyssey for patients, enriches ClinVar with almost 1900 variant interpretations from underrepresented populations, and demonstrates potential cost-effectiveness of integrating WGS into public healthcare. These interim results underscore how national WGS programs can facilitate precision medicine, especially in genetically diverse and previously underrepresented populations.
To develop Brazilian growth charts for weight, height, body mass index (BMI), and head circumference (HC), stratified by sex, for patients with 22q11.2 deletion syndrome (22q11.2DS) from birth to 17 years. This multicenter, retrospective, longitudinal study included 1826 anthropometric data collected through medical record review of 113 patients with a laboratory-confirmed diagnosis of 22q11.2DS who were followed at 11 centers participating in the Craniofacial Brazil Project. The 3rd, 10th, 25th, 50th, 75th, 90th, and 97th percentiles for anthropometric parameters were developed for males and females from birth to 17 years old using the Lambda–Mu–Sigma (LMS) method and graphically compared with reference percentiles from the Centers for Disease Control and Prevention using the Tidyverse package in R software. A growth pattern distinct from that of the reference population was observed, with more pronounced deficits in height and weight during the first two years of life in both sexes. After this period, partial recovery in height was observed, more evident in females, whereas the deficit remained more pronounced in males. Differences in BMI and HC were less marked. The Brazilian growth charts for 22q11.2DS provide more appropriate parameters for clinical monitoring and individualized care of this population.
18 February 2022 in International Journal of Cardiovascular Sciences
Introdução Danon disease (DD) is a rare, dominant X-linked disease caused by mutation of the LAMP2 gene, which encodes a lysosome-associated membrane glycoprotein, thereby affecting lysosomal deposition. DD is characterized by a classic triad of cardiomyopathy (featured by hypertrophic cardiomyopathy [HC]), skeletal myopathy, and cognitive changes. While female patients tend to have milder phenotypic manifestations, an isolated cardiac involvement, in addition to a later onset of symptoms, without the need for heart transplantation before the fourth decade of life, male [...] Introdução Danon disease (DD) is a rare, dominant X-linked disease caused by mutation of the LAMP2 gene, which encodes a lysosome-associated membrane glycoprotein, thereby affecting lysosomal deposition. DD is characterized by a classic triad of cardiomyopathy (featured by hypertrophic cardiomyopathy [HC]), skeletal myopathy, and cognitive changes. While female patients tend to have milder phenotypic manifestations, an isolated cardiac involvement, in addition to a later onset of symptoms, without the need for heart transplantation before the fourth decade of life, male